Cargando…

Tenascin-C: an emerging prognostic biomarker in diabetes

Detalles Bibliográficos
Autores principales:	Yonebayashi, Saori, Tajiri, Kazuko, Li, Siqi, Sato, Akira
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2020
Materias:	Editorial Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7812241/ https://www.ncbi.nlm.nih.gov/pubmed/33490211 http://dx.doi.org/10.21037/atm-2020-116

Ejemplares similares

Immunomodulatory Role of Tenascin-C in Myocarditis and Inflammatory Cardiomyopathy
por: Tajiri, Kazuko, et al.
Publicado: (2021)

Generation of Transgenic Mice that Conditionally Overexpress Tenascin-C
por: Yonebayashi, Saori, et al.
Publicado: (2021)

A Lack of Biomarkers for Cardiac Complications of Immune Checkpoint Inhibitor Therapy
por: Li, Siqi, et al.
Publicado: (2020)

Immunosuppression via Tenascin-C
por: Bellone, Matteo, et al.
Publicado: (2015)

Tenascin‐C Aggravates Autoimmune Myocarditis via Dendritic Cell Activation and Th17 Cell Differentiation
por: Machino‐Ohtsuka, Tomoko, et al.
Publicado: (2014)

MAIR‐II deficiency ameliorates cardiac remodelling post‐myocardial infarction by suppressing TLR9‐mediated macrophage activation
por: Yonebayashi, Saori, et al.
Publicado: (2020)

Nicotinamide Phosphoribosyltransferase (Nampt)/Nicotinamide Adenine Dinucleotide (NAD) Axis Suppresses Atrial Fibrillation by Modulating the Calcium Handling Pathway
por: Feng, Duo, et al.
Publicado: (2020)

Correction: Feng et al. Nicotinamide Phosphoribosyltransferase (Nampt)/Nicotinamide Adenine Dinucleotide (NAD) Axis Suppresses Atrial Fibrillation by Modulating the Calcium Handling Pathway. Int. J. Mol. Sci. 2020, 21, 4655
por: Feng, Duo, et al.
Publicado: (2021)

Characterization of tenascin-C as a novel biomarker for asthma: utility of tenascin-C in combination with periostin or immunoglobulin E
por: Yasuda, Mina, et al.
Publicado: (2018)

Tenascin-W is a better cancer biomarker than tenascin-C for most human solid tumors
por: Brellier, Florence, et al.
Publicado: (2012)

The distribution of tenascin-X is distinct and often reciprocal to that of tenascin-C
Publicado: (1994)

Rev-erb agonist improves adverse cardiac remodeling and survival in myocardial infarction through an anti-inflammatory mechanism
por: Stujanna, Endin Nokik, et al.
Publicado: (2017)

Prognostic Role of Tenascin-C for Cancer Outcome: A Meta-Analysis
por: Ming, Xinliang, et al.
Publicado: (2019)

Tenascin C: A Potential Biomarker for Predicting the Severity of Coronary Atherosclerosis
por: Gao, Wen, et al.
Publicado: (2019)

Neutrophil Elastase Deficiency Ameliorates Myocardial Injury Post Myocardial Infarction in Mice
por: Ogura, Yukino, et al.
Publicado: (2021)

Advances in tenascin-C biology
por: Midwood, Kim S., et al.
Publicado: (2011)

Tenascin-C and integrins in cancer
por: Yoshida, Toshimichi, et al.
Publicado: (2015)

Tenascin C in Lung Diseases
por: Donovan, Chantal, et al.
Publicado: (2023)

Tenascin-C, a Prognostic Determinant of Esophageal Squamous Cell Carcinoma
por: Yang, Zhao-Ting, et al.
Publicado: (2016)

Invasion of Melanoma in Double Knockout Mice Lacking Tenascin‐X and Tenascin‐C
por: Matsumoto, Ken‐ichi, et al.
Publicado: (2002)

Tenascin-C promotes angiogenesis in fibrovascular membranes in eyes with proliferative diabetic retinopathy
por: Kobayashi, Yoshiyuki, et al.
Publicado: (2016)

Advances on the roles of tenascin-C in cancer
por: Yilmaz, Alev, et al.
Publicado: (2022)

Diabetic Nephropathy: Emerging Biomarkers for Risk Assessment
por: Badal, Shawn S., et al.
Publicado: (2015)

Exercise training reduces ventricular arrhythmias through restoring calcium handling and sympathetic tone in myocardial infarction mice
por: Qin, Rujie, et al.
Publicado: (2019)

Tenascin-C in Osteoarthritis and Rheumatoid Arthritis
por: Hasegawa, Masahiro, et al.
Publicado: (2020)

Tenascin-C Suppresses Rho Activation
por: Wenk, Melissa B., et al.
Publicado: (2000)

Tenascin-C: Form versus function
por: Giblin, Sean P, et al.
Publicado: (2014)

Serendipity; Close Encounter of Tenascin C
por: Sakakura, Teruyo
Publicado: (2021)

Emergence of a Predictive Clinical Biomarker for Diabetic Neuropathy
por: Kiernan, Matthew C.
Publicado: (2012)

Extracellular Vesicles: An Emerging Mechanism Governing the Secretion and Biological Roles of Tenascin-C
por: Albacete-Albacete, Lucas, et al.
Publicado: (2021)

Programmed Death-Ligand 2 Deficiency Exacerbates Experimental Autoimmune Myocarditis in Mice
por: Li, Siqi, et al.
Publicado: (2021)

Galectin-3 as an Arrhythmogenic Predictive Marker for Heart Failure
por: Inoue, Keiko, et al.
Publicado: (2022)

A Diverse Range of Cardiac Adverse Events Associated with Immune Checkpoint Inhibitor Therapy
por: Murakata, Yoshiko, et al.
Publicado: (2022)

Neoplastic Cardiac Tamponade
por: Osawa, Takumi, et al.
Publicado: (2023)

The role of tenascin-C in tissue injury and tumorigenesis
por: Midwood, Kim S., et al.
Publicado: (2009)

Raised circulating tenascin-C in rheumatoid arthritis
por: Page, Theresa H, et al.
Publicado: (2012)

Tenascin-C drives persistence of organ fibrosis
por: Bhattacharyya, Swati, et al.
Publicado: (2016)

Tenascin-C: Friend or Foe in Lung Aging?
por: Gremlich, Sandrine, et al.
Publicado: (2021)

Tenascin-C in Heart Diseases—The Role of Inflammation
por: Imanaka-Yoshida, Kyoko
Publicado: (2021)

Stromal tenascin distribution as a prognostic marker in colorectal cancer.
por: Kressner, U., et al.
Publicado: (1997)

Cannot write session to /tmp/vufind_sessions/sess_rv9mecu5v8j8fpgs7nh48569l7